MMedication Read More Artelo ART26.12 Osteoarthritis Study: Relief Like NaproxenJuly 16, 2026 Artelo Biosciences (Nasdaq: ARTL) reported new nonclinical data showing its selective FABP5 inhibitor ART26.12 reduced…
MMental health Read More New Depression Drug Outperforms Zoloft in Memory BenefitsJuly 12, 2025 Artelo Biosciences (Nasdaq: ARTL) has announced promising preclinical results for its drug candidate…